Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Immunovia AB
At $1.2 billion, Q4 device financing was the second-lowest quarter of 2015; M&A dollar volume was also low, but included multiple deals across various cardiovascular markets. Diagnostics financing was also down in Q4, totaling $403 million; acquisitions were worth $441 million.
- In Vitro Diagnostics
- Laboratory Testing Services
In Vitro Diagnostics
- Hematology, Coagulation
Drug Discovery Tools
- Large Molecule
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.